Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Raphael Pharmaceutical Inc. (RAPH) had Return on Tangible Equity of 21.14% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.27M |
|
-- |
|
-- |
|
$0.25M |
|
$-0.25M |
|
$-0.05M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.25M |
|
$-0.25M |
|
19.55M |
|
19.55M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.05M |
|
$0.00M |
|
$0.00M |
|
$0.05M |
|
$1.49M |
|
-- |
|
-- |
|
$1.49M |
|
$-1.43M |
|
$-1.43M |
|
$-1.43M |
|
20.18M |
|
| Cash Flow Statement Financials | |
$-0.21M |
|
-- |
|
$0.24M |
|
$0.02M |
|
$0.04M |
|
$0.03M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.14% |
|
|
Return on Tangible Equity |
21.14% |
-571.70% |
|
21.14% |
|
$-0.07 |
|
$-0.01 |
|
$-0.01 |
|